Especialidades y enfermedades  

Farmacéuticas. 17 de mayo de 2018

Internationalisation and regulatory reform driving growth and investment at CPhI China

Amsterdam, 17 May 2018: CPhI & P-MEC China (#CPhIChina) – organized by UBM and UBM SINEXPO – takes place at the Shanghai New International Expo Center (SNIEC) on 20-22nd June 2018. Asia’s largest pharmaceutical event returns with recent regulatory reforms stimulating international interest in the region, as the CFDA is harmonising China’s regulatory environment with the rest of the pharmaceutical world. The event will be co-located with ICSE, InnoPack, BioPh, Labworld, NEX, EP & Clean Tech, FDF, P-Logi, and Excipients.
Farmacéuticas. 08 de mayo de 2018

WuXi STA Changzhou Site Passes First U.S. FDA Inspection

The integrated R&D and manufacturing facility is expecting more products to go into commercial production post approval
Farmacéuticas. 27 de abril de 2018

WuXi STA to build new R&D center in Shanghai

SHANGHAI, April 27, 2018: STA Pharmaceutical Co., Ltd., a subsidiary of WuXi AppTec (WuXi STA), announces that it has signed an investment agreement with the government of Shanghai, Jinshan District to build a new R&D center. The new facility will further strengthen WuXi STA’s global leading pharmaceutical development and manufacturing platform, enabling drug developers to accelerate their projects from preclinical to commercial stage.
Farmacéuticas. 24 de abril de 2018

ADC Bio secures £1.14m investment from Downing LLP to finance innovative bioconjugation and US expansion

Funding earmarked for US market penetration and development of groundbreaking upstream bioconjugation approach
Farmacéuticas. 19 de abril de 2018

Phoenix Molecular Designs Announces Manufacturing Collaboration with WuXi STA to advance PMD-026 toward IND

VANCOUVER, British Columbia and SAN DIEGO, April 19, 2018: Phoenix Molecular Designs (PhoenixMD), a privately-held biotechnology company designing precise cancer therapeutics by targeting essential kinases, announced that it has entered into a collaboration with STA Pharmaceutical Co., Ltd (STA), a WuXi AppTec group company, to manufacture the PMD-026 needed for IND-enabling toxicology studies and a Phase I study in women.
Farmacéuticas. 09 de abril de 2018

CPhI South East Asia strengthens ASEAN integration by opening Thailand edition in 2019

Amsterdam, 9th April 2018: CPhI South East Asia – organised by UBM – has announced that from 2019 onwards it will alternate its annual location between the region’s two largest pharma economies, Indonesia and Thailand
Farmacéuticas. 26 de marzo de 2018

bioLIVE to introduce global biopharma country ranking

Global analysis will rank each major biomanufacturing country’s market growth potential, innovation and competitiveness  
Farmacéuticas. 21 de marzo de 2018

Envigo expands Livermore (USA) surgical facilities to meet rising demand from West Coast companies

Facility to increase footprint ten-fold with doubling of surgical technicians, becoming the Envigo West Coast Centre of Excellence for surgery


Subir notas de prensa y convocatorias

Próximas convocatorias   


Busca notas de prensa por especialidad médica o enfermedad.

Ver todas


Busca notas de prensa por su fecha de edición.

  Selecciona el año

Copyright © 2018, Farmavet, S.L. Todos los derechos reservados.